These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Use of (18)F-FDG PET/CT in the preoperative evaluation of patients diagnosed with peritoneal carcinomatosis of ovarian origin, candidates to cytoreduction and hipec. A pending issue. Lopez-Lopez V, Cascales-Campos PA, Gil J, Frutos L, Andrade RJ, Fuster-Quiñonero M, Feliciangeli E, Gil E, Parrilla P. Eur J Radiol; 2016 Oct 01; 85(10):1824-1828. PubMed ID: 27666623 [Abstract] [Full Text] [Related]
6. [Mesothelioma staging with ¹⁸F-FDG PET/CT. A case report with simultaneous pleural and peritoneal infiltration]. Moreno C, Soler M, Mourelo S, Moragas M, Riera E, Garcia JR. Rev Esp Med Nucl Imagen Mol; 2015 Oct 01; 34(2):141-2. PubMed ID: 25049160 [No Abstract] [Full Text] [Related]
7. Extensive Metastases on 18F-FDG PET/CT in Primary Lymphoepithelioma-Like Carcinoma of the Ovary. Yoon SN. Clin Nucl Med; 2016 Nov 01; 41(11):e482-e484. PubMed ID: 27607167 [Abstract] [Full Text] [Related]
8. [Peritoneal carcinomatosis from ovarian cancer: role of 18F-FDG-PET/CT and CA125]. Rubini G, Altini C, Notaristefano A, Merenda N, Rubini D, Stabile Ianora AA, Giganti M, Niccoli Asabella A. Recenti Prog Med; 2012 Nov 01; 103(11):510-4. PubMed ID: 23096741 [Abstract] [Full Text] [Related]
9. Evaluation of recurrence in gastric carcinoma: Comparison of contrast-enhanced computed tomography and positron emission tomography/computed tomography. Kim JH, Heo SH, Kim JW, Shin SS, Min JJ, Kwon SY, Jeong YY, Kang HK. World J Gastroenterol; 2017 Sep 21; 23(35):6448-6456. PubMed ID: 29085194 [Abstract] [Full Text] [Related]
10. The role of 18F-FDG-PET/ceCT in peritoneal mesothelioma. Dubreuil J, Giammarile F, Rousset P, Rubello D, Bakrin N, Passot G, Isaac S, Glehen O, Skanjeti A. Nucl Med Commun; 2017 Apr 21; 38(4):312-318. PubMed ID: 28244976 [Abstract] [Full Text] [Related]
13. Molecular Imaging of Peritoneal Carcinomatosis in Ovarian Carcinoma. Lee EYP, An H, Tse KY, Khong PL. AJR Am J Roentgenol; 2020 Aug 21; 215(2):305-312. PubMed ID: 32551907 [Abstract] [Full Text] [Related]
14. PET/CT for differentiating between tuberculous peritonitis and peritoneal carcinomatosis: The parietal peritoneum. Wang SB, Ji YH, Wu HB, Wang QS, Zhou WL, Lv L, Shou T, Hu J. Medicine (Baltimore); 2017 Jan 21; 96(2):e5867. PubMed ID: 28079823 [Abstract] [Full Text] [Related]
15. The emerging roles of functional imaging in ovarian cancer with peritoneal carcinomatosis. An H, Lee EYP, Chiu K, Chang C. Clin Radiol; 2018 Jul 21; 73(7):597-609. PubMed ID: 29685803 [Abstract] [Full Text] [Related]
16. Gastrointestinal stromal tumour with unusual sites of metastasis: accurate staging with ¹⁸F-FDG PET/CT. Mukherjee A, Karunanithi S, Singla S, Bal C, Kumar R. Rev Esp Med Nucl Imagen Mol; 2015 Jul 21; 34(1):60-1. PubMed ID: 25263720 [No Abstract] [Full Text] [Related]
18. 18F-FDG PET/CT in a recurrent diffuse malignant peritoneal mesothelioma. Cao Q, Lu M, Heath J, Hausner PF, Alexander HR, Dilsizian V, Chen W. Clin Nucl Med; 2012 May 21; 37(5):492-4. PubMed ID: 22475902 [Abstract] [Full Text] [Related]
19. Incidental finding of Psuedomyxoma Peritonei in Malignant Peripheral Nerve Sheath Tumour. Gill SM, Waseem M, Bashir H, Hassan A. J Pak Med Assoc; 2024 May 21; 74(5):1007-1008. PubMed ID: 38783460 [Abstract] [Full Text] [Related]
20. 18F-FDG Uptake of Localized Malignant Peritoneal Mesothelioma. Kodama E, Kodama T, Ichikawa T, Ikoma H, Hashimoto J. Clin Nucl Med; 2020 Feb 21; 45(2):161-163. PubMed ID: 31876833 [Abstract] [Full Text] [Related] Page: [Next] [New Search]